The Global Medtech Industry: Rewiring Medtech in a Post-Pandemic World

The medtech industry is undergoing rapid change to address evolving global market dynamics. This has been further accelerated by the pandemic. This white paper from IQVIA – an associate member of AdvaMed – discusses how global markets and specific therapeutic areas are poised for growth over the next decade. Read this white paper to help inform business strategy.
Related Reading
Event / China / Global & Trade / Government & Legislative Affairs / Supply Chain
Tariffs 101: Understanding the Impact of New Tariff Policies (Members Only)
February 27, 2025: 3:00 PM – 4:00 PM
This educational primer will break down tariffs, trade policies, and legal frameworks—giving you the basics you need to navigate upcoming changes.
News / Global & Trade
Medtech POV Podcast: Rep. Brad Wenstrup on COVID-19 Lessons, Common Sense in Health Care, and Treating Shooting Victim Scalise
February 12, 2025
On the Medtech POV podcast, AdvaMed President and CEO Scott Whitaker sat down with recently retired U.S. Rep. Brad Wenstrup of Ohio, discussing lessons learned from the COVID-19 pandemic, illogical budgetary scoring of health care procedures, and Wenstrup’s life-saving triage of U.S. House of Representatives Majority Leader Steve Scalise after a shooting.
News / Global & Trade
AdvaMed Seeks Medical Technology Exemption from All Tariffs
February 1, 2025
AdvaMed, the Medtech Association, today released the following statement from President and CEO Scott Whitaker following the imposition of tariffs on products from Canada, Mexico, and China:
Resource / Global & Trade / Supply Chain
EY 18th annual Pulse of the MedTech Industry Report
October 25, 2024
The 18th annual Pulse of the MedTech Industry report finds the medical technology industry continuing to push at new frontiers, as ongoing breakthroughs in MedTech AI and renewed hope for MedTech M&A hold out the possibility of making devices smarter, smaller and more personalized.
News / Global & Trade
AdvaMed Welcomes India, New Member Countries from Latin America, Middle East, Africa to IMDRF
October 10, 2024
The International Medical Device Regulators Forum (IMDRF) consists of medical device regulators from around the world that voluntarily convene to harmonize the regulatory requirements for medical products varying from country to country. The U.S. FDA is the Chair and Secretariat of the IMDRF for 2024 and recently hosted its 26th session. The IMDRF added 15 new affiliate members this year (Botswana, Costa Rica, Dominican Republic, El Salvador, Ethiopia, Kenya, India, Jordan, México, Oman, Nigeria, Paraguay, Peru, Tanzania, and Zimbabwe).
News / Code of Ethics / Global & Trade
AdvaMed Welcomes APEC Recommendations for Enterprise Integrity and Public Procurement
September 23, 2024
News / Global & Trade
AdvaMed Signs New MOU with British Medtech Association
June 26, 2024
AdvaMed, the Medtech Association, signed a renewed memorandum of understanding with the Association of British HealthTech Industries (ABHI) to strengthen the relationship between two of the leading medtech organizations in the world.
News / Global & Trade
AdvaMed Statement on FDA-USAID India Regulatory Session
April 16, 2024
AdvaMed, the Medtech Association, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring medical technology reaches patients. The event, called “Minds to Markets: Regulatory Considerations in Med-Tech,” advances US-India cooperation on medtech supply chain through greater regulatory alignment.